| Economic evaluations of clinical pharmacy services: 2006–2010 DR Touchette, F Doloresco, KJ Suda, A Perez, S Turner, Y Jalundhwala, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (8 …, 2014 | 175 | 2014 |
| Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease SL Saraf, AL Oh, PR Patel, Y Jalundhwala, K Sweiss, M Koshy, ... Biology of Blood and Marrow Transplantation 22 (3), 441-448, 2016 | 136 | 2016 |
| Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients A Fasano, VSC Fung, L Lopiano, B Elibol, IG Smolentseva, K Seppi, ... BMC neurology 19, 1-11, 2019 | 93 | 2019 |
| The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States P Martinez‐Martin, D Macaulay, YJ Jalundhwala, F Mu, E Ohashi, ... Movement Disorders 34 (2), 236-245, 2019 | 79 | 2019 |
| Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database D Wendling, A Joshi, P Reilly, YJ Jalundhwala, M Mittal, Y Bao Current medical research and opinion 30 (12), 2515-2521, 2014 | 76 | 2014 |
| The “Seven Pillars” response to patient safety incidents: effects on medical liability processes and outcomes BL Lambert, NM Centomani, KM Smith, LA Helmchen, DK Bhaumik, ... Health services research 51, 2491-2515, 2016 | 59 | 2016 |
| Effect of levodopa‐carbidopa intestinal gel on non‐motor symptoms in patients with advanced Parkinson's disease DG Standaert, RL Rodriguez, JT Slevin, M Lobatz, S Eaton, K Chatamra, ... Movement Disorders Clinical Practice 4 (6), 829-837, 2017 | 58 | 2017 |
| Systematic review and meta‐analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions SJ Snedecor, L Sudharshan, JC Cappelleri, A Sadosky, P Desai, ... International Journal of Clinical Practice 68 (7), 900-918, 2014 | 52 | 2014 |
| Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection E Lawitz, R Flisiak, M Abunimeh, ME Sise, JY Park, M Kaskas, ... Liver International 40 (5), 1032-1041, 2020 | 50 | 2020 |
| Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury SJ Snedecor, L Sudharshan, JC Cappelleri, A Sadosky, P Desai, ... Journal of pain research, 539-547, 2013 | 49 | 2013 |
| The long-term impact of levodopa/carbidopa intestinal gel on ‘off’-time in patients with advanced Parkinson’s disease: a systematic review A Antonini, P Odin, R Pahwa, J Aldred, A Alobaidi, YJ Jalundhwala, ... Advances in therapy 38 (6), 2854-2890, 2021 | 47 | 2021 |
| The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease J Lowin, K Sail, R Baj, YJ Jalundhwala, TS Marshall, H Konwea, ... Journal of medical economics 20 (11), 1207-1215, 2017 | 34 | 2017 |
| Burden of Parkinson's disease by severity: health care costs in the US medicare population N Dahodwala, P Li, J Jahnke, VP Ladage, AR Pettit, PL Kandukuri, Y Bao, ... Movement Disorders 36 (1), 133-142, 2021 | 29 | 2021 |
| Validation and clinical value of the MANAGE-PD tool: a clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications A Antonini, P Odin, P Schmidt, F Cubillos, DG Standaert, T Henriksen, ... Parkinsonism & related disorders 92, 59-66, 2021 | 28 | 2021 |
| Abdominal compartment syndrome in trauma patients: New insights for predicting outcomes AW Shaheen, ML Crandall, NG Nicolson, E Smith-Singares, GJ Merlotti, ... Journal of emergencies, trauma, and shock 9 (2), 53-57, 2016 | 28 | 2016 |
| Lifestyle-related attitudes: do they explain self-rated health and life-satisfaction? AS Pickard, YJ Jalundhwala, H Bewsher, LK Sharp, SM Walton, ... Quality of Life Research 27, 1227-1235, 2018 | 15 | 2018 |
| Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries IA Malaty, P Martinez-Martin, KR Chaudhuri, P Odin, M Skorvanek, ... BMC neurology 22 (1), 35, 2022 | 14 | 2022 |
| Effects of levodopa-carbidopa intestinal gel on dyskinesia and non-motor symptoms including sleep: results from a meta-analysis with 24-month follow-up K Chaudhuri, A Antonini, R Pahwa, P Odin, N Titova, S Thakkar, ... Journal of Parkinson's disease 12 (7), 2071-2083, 2022 | 11 | 2022 |
| Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity N Dahodwala, AR Pettit, J Jahnke, P Li, VP Ladage, PL Kandukuri, ... Clinical Parkinsonism & Related Disorders 3, 100046, 2020 | 11 | 2020 |
| Addressing barriers to hepatitis C virus (HCV) elimination: real-world outcomes in historically underserved patients with chronic HCV infection treated with glecaprevir … P Lampertico, M Peck-Radosavljevic, MI Bondin, W Mazur, L Magenta, ... Hepatology 70, 954A-955A, 2019 | 10 | 2019 |
